Question 1

What is LOPJLB’s current signal on CASI?

Accepted Answer

LOPJLB’s latest quantitative signal on CASI Pharmaceuticals, Inc. (CASI) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is CASI in?

Accepted Answer

CASI Pharmaceuticals, Inc. (CASI) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does CASI Pharmaceuticals, Inc. (CASI) do?

Accepted Answer

CASI Pharmaceuticals, Inc. is a biopharmaceutical firm focused on the development and market introduction of medical treatments and drugs across China, the United States, and globally. Its marketed product, EVOMELA, is an intravenous formulation of melphalan, utilized for conditioning prior to stem cell transplantation and as a palliative option for patients suffering from multiple myeloma. The…

Question 4

Where is CASI Pharmaceuticals, Inc. based / listed?

Accepted Answer

CASI Pharmaceuticals, Inc. is based in CN, listed on NASDAQ.

CASI Pharmaceuticals, Inc. (CASI)

Key stats

Prediction markets

Company news